Abeona Therapeutics

News

Abeona Therapeutics' Zevaskyn has been approved in the US as a treatment for the rare skin disorder recessive dystrophic epidermolysis bullosa (DEB).

News

According to multiple press reports citing anonymous insider sources, Dr Martin Makary has resigned after a year at the head of the FDA.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.